Los puntos clave no están disponibles para este artículo en este momento.
CD19-targeted CAR T cells show sustained CD19 + B cell depletion and profound therapeutic benefit in ameliorating disease in mouse models of lupus.
Kansal et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: